Nicole Murphy
CIK: 0001910644
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BIOGEN INC.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Feb 13, 2026BIIB
BIOGEN INC.
Award(A)DirectRestricted Stock Unit
10.6K shares- - Feb 12, 2026BIIB
BIOGEN INC.
Purchase(P)Direct3 shares at avg. $195.03$585.105 - Feb 6, 2026BIIB
BIOGEN INC.
Exercise(M)Direct2.1K shares- - Feb 6, 2026BIIB
BIOGEN INC.
Tax Payment(F)Direct1K shares at avg. $201.18$205K - Feb 6, 2026BIIB
BIOGEN INC.
Exercise(M)Direct1.9K shares- - Feb 6, 2026BIIB
BIOGEN INC.
Tax Payment(F)Direct914 shares at avg. $201.18$184K - Feb 6, 2026BIIB
BIOGEN INC.
Exercise(M)Direct4.7K shares- - Feb 6, 2026BIIB
BIOGEN INC.
Tax Payment(F)Direct1.4K shares at avg. $201.18$283K - Feb 10, 2025BIIB
BIOGEN INC.
Exercise(M)Direct2.3K shares- - Feb 10, 2025BIIB
BIOGEN INC.
Tax Payment(F)Direct670 shares at avg. $142.54$96K - Feb 7, 2025BIIB
BIOGEN INC.
Tax Payment(F)Direct603 shares at avg. $141.35$85K - Feb 7, 2025BIIB
BIOGEN INC.
Exercise(M)Direct2.1K shares- - Feb 7, 2025BIIB
BIOGEN INC.
Exercise(M)Direct1.9K shares- - Feb 7, 2025BIIB
BIOGEN INC.
Tax Payment(F)Direct620 shares at avg. $141.35$88K - Feb 6, 2025BIIB
BIOGEN INC.
Award(A)DirectRestricted Stock Unit
14.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 13, 2026 | BIIB BIOGEN INC. | Award(A) Restricted Stock Unit | 10,560 | - | - | Direct |
| Feb 12, 2026 | BIIB BIOGEN INC. | Purchase(P) | 3 | $195.03 | $585 | Direct |
| Feb 6, 2026 | BIIB BIOGEN INC. | Exercise(M) | 2,102 | - | $0 | Direct |
| Feb 6, 2026 | BIIB BIOGEN INC. | Tax Payment(F) | 1,017 | $201.18 | $204,600 | Direct |
| Feb 6, 2026 | BIIB BIOGEN INC. | Exercise(M) | 1,940 | - | $0 | Direct |
| Feb 6, 2026 | BIIB BIOGEN INC. | Tax Payment(F) | 914 | $201.18 | $183,879 | Direct |
| Feb 6, 2026 | BIIB BIOGEN INC. | Exercise(M) | 4,683 | - | $0 | Direct |
| Feb 6, 2026 | BIIB BIOGEN INC. | Tax Payment(F) | 1,408 | $201.18 | $283,261 | Direct |
| Feb 10, 2025 | BIIB BIOGEN INC. | Exercise(M) | 2,272 | - | - | Direct |
| Feb 10, 2025 | BIIB BIOGEN INC. | Tax Payment(F) | 670 | $142.54 | $95,502 | Direct |
| Feb 7, 2025 | BIIB BIOGEN INC. | Tax Payment(F) | 603 | $141.35 | $85,234 | Direct |
| Feb 7, 2025 | BIIB BIOGEN INC. | Exercise(M) | 2,102 | - | - | Direct |
| Feb 7, 2025 | BIIB BIOGEN INC. | Exercise(M) | 1,940 | - | - | Direct |
| Feb 7, 2025 | BIIB BIOGEN INC. | Tax Payment(F) | 620 | $141.35 | $87,637 | Direct |
| Feb 6, 2025 | BIIB BIOGEN INC. | Award(A) Restricted Stock Unit | 14,050 | - | - | Direct |
1-15 of 15 transactions
About Murphy Nicole
Murphy Nicole (SEC CIK 0001910644) files insider reports with the SEC as Head of Pharm Ops and Tech of BIOGEN INC. (BIIB).
Signal8 holds 4 ownership filings by Murphy Nicole, all Form 4s, filed between Feb 10, 2025 and Feb 17, 2026. Those filings report 15 transactions, from Feb 6, 2025 to Feb 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Murphy Nicole's filings is in CAMBRIDGE, MA.
Recent filings by Murphy Nicole
- Feb 13, 2026: Grant or award of BIIB derivative securities (Form 4, code A).
- Feb 12, 2026: Open-market purchase of BIIB shares (Form 4, code P).
- Feb 6, 2026: Option exercise of BIIB shares (Form 4, code M).
- Feb 6, 2026: Tax withholding of BIIB shares (Form 4, code F).
- Feb 6, 2026: Option exercise of BIIB shares (Form 4, code M).
Other insiders filing for BIOGEN INC. (BIIB)
- Grogan Jane, Head of Research
- Godbout Sean, Chief Accounting Officer
- Parini Michael, Chief Legal Officer
- Minor Lloyd, Director
- HAWKINS WILLIAM A, Director
- SHERWIN STEPHEN A, Director